Cairo – Mubasher: The Extraordinary General Assembly of GlaxoSmithKline approved, by 99.99% of the votes of the attending shareholders following excluding the main shareholder’s vote, the sale of movable consumer healthcare assets (not including real estate and machinery) and intangible assets.
The company added, in a statement to the Egyptian Stock Exchange, today: “It is stipulated in the fair value study report prepared by the independent financial advisor to GSK Consumer Hellenker Egypt Ltd. held on October 19, 2021.
GlaxoSmithKline had said that it was decided to establish a new company to engage in consumer health care activity, with GlaxoSmithKline continuing to manufacture and market medicines and vaccines.
To trade and invest in the Egyptian Stock Exchange, click here
Recommendations:
The Egyptian Medicines Company agrees to separate the healthcare assets of GlaxoSmithKline
